|

Amrubicin (Japan only) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Gilead Sciences1

Indications

  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)1
  • Lung Cancer1
  • Cancer1

Anaheim, California1 trial

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Los Angeles Cancer Network

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.